The America Invents Act of 2011 formed the Patent Trial and Appeal Board (PTAB) and replaced inter partes patent reexamination with two inter partes dispute proceedings: inter partes review (IPR) and post-grant review (PGR). (Ex parte patent reexaminations continue to be available for unexpired U.S. patents).

IPR and PGR will introduce new, court-like elements to patent office proceedings, injecting new strategic considerations and requiring experience and skills new to patent office advocacy.

Kilpatrick Townsend's Patent Reexamination & Inter Partes Disputes team draws on its patent prosecution and patent litigation practices that are each among the largest in the world. These practices provide an unmatched combination of deep experience and skill in both patent offices and courts with comprehensive science and engineering academic credentials and industrial experience.

Our Patent Reexamination & Inter Partes Disputes team has represented patent owners and challengers in more than 100 U.S. patent reexamination proceedings and is well-experienced with European opposition proceedings that are quite similar to the new U.S. proceedings. Our litigators conduct focused and efficient discovery and are masters of the courtroom, coupling penetrating cross examinations with winning oral arguments, skills and experience that will be essential in the new IPR and PGR proceedings.

In short, Kilpatrick Townsend’s team has the credentials, expertise, experience and judgment to guide its clients successfully through the challenges of the new IPR and PGR proceedings.

Patent Reexamination & Inter Partes Disputes

Experience Highlights

Patent reissue for wireless telecommunication company
Representing a wireless telecommunication patent owner in a broadening reissue application, where the subject patent is part of an international more
Patent reexamination for Austin Hughes Electronics Ltd.
Successfully obtained a final determination for our client Austin Hughes Electronics Ltd., rejecting the claims in an inter partes more
Patent reexamination for consumer health company
Successfully represented the patent owner (five patents) in ex parte reexaminations (involving concurrent litigation) brought by a large more
Patent reexamination for Prometheus Laboratories Inc.
Represented Prometheus Laboratories, Inc. owner of an Orange Book listed branded drug, Lotronex (alosetron hydrochloride), indicated for women with more

Contact Us